Extract physiologic variations in plasma F F A levels on the degree of ~ DPH binding we have examined the correlation between these '
The binding of d i~h e n~l h~d a n t o i n (DPH) '0 plasma proteins variables in a group of newborn infants. animal experiments was studied with a n equilibrium dialysis method in plasmas in we have also studied the effect on DPH protein binding of a , which concentrations of free fatty acids (FFA;) were varied rise in plasma FFA induced by sympathetic nerve 
IN SITU PERFUSED DOG ADIPOSE TISSUE
Dogs were anaesthetized with sudium pentobarbital (30 Speculation mg/kg) and tracheostomized. Inguinal adipose tissue was isolated as described elsewhere (4) . The nerve t o the tissue was
Our data indicate that physiologically occurring variations in stimulated electrically (4 HZ, 12 V, 2 msec for 30-60 m k ) . plasma FFA concentration can alter the plasma protein The venous outflow was collected in ice-cooled centrifuge binding of drugs-We Propose that such displacement will be tubes and the blood cells were removed by centrifugation. The quantitatively most important in blood perfusing adipose plasma was subsequently analyzed for FFA content (22) and tissue during lipolysis and that the effect might lead t o a DPH binding as described below. preferential distribution of the drug to fat tissue during lipolysis.
IN VITRO EXPERIMENTS
Male Sprague-Dawley rats (190-220 g) were killed by a Several drugs including DPH are bound t o plasma proteins, blow on the neck. The epididymd fat pads were removed and blotted on filter paper and weighed. The tissues were mainly albumin, in newborn infants as well as in adults (12, 16 born at term; 37 had a normal birth weight, 3 were overweight, and 2 were underweight according t o gestational age and sex (21) . Cord blood was obtained from 2 1 infants, all of whom had an uneventful neonatal period. Blood was taken into heparinized tubes from the maternal end of the cord immediately after birth and before the placenta was delivered. The remaining 21 infants were observed or treated in the pediatric department for different reasons: maternal diabetes, prenatal asphyxia, hyperbilirubinemia, hypoglycemia, feeding problems, neonatal infections. In these cases venous blood was obtained at different times during the first week after birth in connection with sampling for diagnostic purposes. Blood was drawn from a cubitalovein into a heparinized syringe. All samples were kept at 4 ; plasma was separated by centrifugation within 15 min after sampling and was protected from light until analysis the following day. Plasma concentrations of F F A ( l o ) , bilirubin (6, 13), albumin (from total protein determination by refractometry and separation of protein fractions on cellulose .acetate by microzone electrophoresis (24)), and protein binding of DPH (as described below) were determined in duplicate.
ASSAY OF PROTEIN BINDING
Protein binding of DPH was studied with an equilibrium dialysis method (3) using cells of Lucite, divided into two equal compartments by a cellophane membrane. Only 0.5 ml plasma is required in this method. 14c-labeled DPH (specific activity approximately 5 mCi/mM (25)) was diluted with unlabeled DPH (1:4) and added t o the plasma sample on one side of the membrane at a total concentration of 15 pg/ml. Equilibrium with the other side of the membrane, containing a sodium p h~s p h a t e~b u f f e r , pH 7.38, was achieved after 6 hr of incubation at 3 7 . The unbound fraction of the drug was determined from the ratio of radioactivity between the buffer and plasma phases. Radioactivity was measured in a Packard 28 FREDHOLM, RAl VE. AND PERSSON Tri-Carb using Instagel as scintillation medium. Quenching by bilirubin was corrected for by automatic external standardization.
RESULTS
The stimulation of the sympathetic nerve to inguinal adipose tissue led t o an increase in the venous plasma FFA concentration from resting values ranging from 0.26-0.58 mM. The peak venous concentration in six dogs ranged between 0.63 and 3.44 mM. In Figure 1 
Results from an in vitro experiment are shown in Table 2 . Noradrenaline (NA) (1 pM) increased lipolysis and the medium FFA concentration. At the same time the distribution of [' 4~] DPH added t o the incubation medium was bound less t o proteins and more t o the tissue. NA per se had n o effect on plasma protein binding. Results from the same experiment are plotted in Figure 2 t o demonstrate the linear relation between the association of the drug with tissue and the relative proportion of unbound drug. The points in the figure represent incubations in the presence or in the absence of NA, which suggests that the effect of NA on tissue binding is due t o changes in the plasma protein binding of the drug. Moreover, tlie results indicate that the affinity of DPH for adipose tissue is approximately 3 times higher than that for the plasma water phase.
NEWBORN INFANTS
The individual concentrations of FFA, bilirubin, albumin, as well as the binding of DPH in vitro, expressed as percentage of unbound drug, are given in Table 1 . We formed the FFA t o albumin and bilirubin t o albumin ratios, inasmuch as these variables are more meaningful in an analysis of drug binding than the absolute concentrations of F F A and bilirubin. The ;dog2 (0) 8 kg, hematocrit 44.5, adipose tissue weight 32.0 g, blood flow 7.76 ml X miK' X 100 g' . The tissue was prepared as described in Methods. Venous plasma was sampled during resting conditions and pooled. The sympathetic nerve was stimulated with 4 Hz, 12 V, 2 msec for 1 hr or more. Venous samples were sampled continuously. Pooled samples were used for the determination of plasma protein binding of diphenylhydantoin at a concentration of 15 ~g l m l . mutual relation between these variables was determined by the correlation coefficient. Both the ordinary correlation coefficient, assuming a bivariate normal distribution, and the partial correlation coefficient, assuming a multivariate normal distribution, are given in Table 3 . Plasma protein binding correlated best with the bilirubin t o albumin concentration, but the relations t o FFA t o albumin and the albumin concentration were also significant.
DISCUSSION
In a detailed study on drug binding t o human serum albumin, Rudman et al. (1 7 ) showed that F F A decrease the binding of several drugs such as salicylic acid, phenylbutazone, bishydroxycoumarin, and DPH. From kinetic analyses the authors concluded that besides displacement, other factors such as conformational changes of the albumin molecule might be responsible for this effect of FFA. These authors also studied the drug binding in rabbit sera, in which the F F A concentration was elevated by ACTH. They found a significantly decreased binding at 2.2-3.0 mM FFA.
We have increased the plasma FFA concentrations in the dog in a physiologic manner by stimdlation of sympathetic nerves t o the isolated perfused canine adipose tissue. It should be pointed out that nerve stimulation of the blood perfused adipose tissue causes little or n o change in the plasma albumin Table 3 (17) . Similarly, the unbound fraction of DPH increased when the plasma FFA concentration was increased by lipolysis in vitro (Table 2 ). This finding is significant in view of the linear relation between the percentage of unbound DPH and the accumulation of the drug in the tissue under the same circumstances. When taken together, these results suggest that lipolysis, by causing an increased release of FFA, can decrease the binding of drugs t o plasma proteins and hence the accumulation of drugs in fat. This mechanism might explain the results of Kniewald et al. (7, 8) which show an increased tissue binding of phenobarbital and DPH in fat during lipolytic conditions, whether induced in vivo by starvation or in vitro by the addition of lipolytic agents.
. Correlations between albumin concentration (I), free fatty acids to albumin concentmtion ratio (II), bilirubin to albumin concentration ratio (III), and the percentage of unbound [' C] diphenylhydantoin in plasmas from newborn infants (IV)'
In the immediate neonatal period there are large variations in FFA both within and between individuals (15). The above findings suggested that newborn infants might exhibit considerable differences in the degree of DPH binding caused by such variations in FFA. In these infants there are also considerable differences in bilirubin concentration. In a previous study it was shown that hyperbilirubinemic children bind significantly less DPH than normal (16) . However, the plasma FFA concentrations were not investigated in that study. It was therefore considered to be of interest to evaluate the importance of both FFA and bilirubin on the plasma protein binding.
When considered in isolation, by the use of partial correlation analysis, both of these factors, as well as the concentration of albumin, were found to correlate significantly with the degree of DPH binding. Our results have thus shown that physiologically occurring variations in FFA can influence the degree of drug binding in newborn infants as well as in experimental animals.
The displacement of drugs from plasma proteins may alter the therapeutic effect, although the clinical importance of the phenomenon often has been overemphasized. If the drug distributes in the total body water, it can be calculated that displacement from protein binding sites would produce a clinically important increase in the unbound fraction only if the drug binding were greater than 90%. DPH has a relatively large volume of distribution (approximately 0.6 literslkg body wt (14) and in the present study we found less than 90% binding of the drug. It must be concluded that it is unlikely that the observed displacement of DPH by FFA is of major clinical significance. For other drugs the effect might be of greater importance, especially if the FFA concentration reaches very high values. The results of Rudman et al. (17) and of Starinsky and Shafrir (20) similarly suggest that only extreme FFA concentrations significantly alter drug and bilirubin binding to serum albumin.
Such very high concentrations of FFA are likely to occur primarily in the blood perfusing adipose tissue during lipolysis. Thus one might speculate that FFA could play a more localized role by decreasing drug binding to plasma proteins in blood perfusing fat tissue. This could lead t o a preferential distribution of drug to organs displaying a high rate of lipolysis. The results of Kniewald et al. (7, 8) are certainly compatible with this hypothesis.
SUMMARY
It has been shown that increasing the concentration of FFA in plasma by lipolysis, either in perfused dog subcutaneous adipose tissue or rat epididymal adipose tissue, leads to a decreased DPH binding to plasma proteins. Furthermore, such an increase in the concentration of free drug is associated with an increased accumulation of drug in fat tissue. In plasma from newborn infants, DPH binding was found to correlate with the albumin concentration, the bilirubin to albumin, and the FFA to albumin concentration ratios.
